FDA Issues Guidance Documents On Exploratory INDs

Drug Industry Daily
KEYWORDS FDA / Guidances
A A

The FDA has released a series of guidances and a final rule aimed at speeding products to market by streamlining the investigational new drug (IND) application process.

To View This Article:

Login

Subscribe To Drug Industry Daily